This paper is in the following e-collection/theme issue:

Pharmacovigilance (134) Electronic/Mobile Data Capture, Internet-based Survey & Research Methodology (832) Participatory Epidemiology and Surveillance (119)

Published on in Vol 1, No 2 (2015): Jul-Dec

Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy

Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy

Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy

Authors of this article:

Nancy A Dreyer1 Author Orcid Image ;   Stella CF Blackburn2 Author Orcid Image ;   Shahrul Mt-Isa3 Author Orcid Image ;   Jonathan L Richardson4, 5 Author Orcid Image ;   Simon Thomas4, 5 Author Orcid Image ;   Maja Laursen6 Author Orcid Image ;   Priscilla Zetstra-van der Woude7 Author Orcid Image ;   Anna Jamry-Dziurla8 Author Orcid Image ;   Valerie Hliva9 Author Orcid Image ;   Alison Bourke10 Author Orcid Image ;   Lolkje de Jong-van den Berg7 Author Orcid Image
Article Authors Cited by (23) Tweetations (4) Metrics

Journals

  1. Richardson J, Stephens S, Thomas S, Jamry-Dziurla A, de Jong-van den Berg L, Zetstra - van der Woude P, Laursen M, Hliva V, Mt-Isa S, Bourke A, Dreyer N, Blackburn S. An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy. JMIR Public Health and Surveillance 2016;2(1):e13 View
  2. Laursen M, Hallgreen C, Dreyer N, Bourke A, Mt‐Isa S, Blackburn S. Comparison of electronic self‐reported prescription medication use during pregnancy with the national prescription register in Denmark. Pharmacoepidemiology and Drug Safety 2020;29(3):328 View
  3. Ley C, Willis L, de la Luz Sanchez M, Parsonnet J, Fischer F. Recall accuracy of weekly automated surveys of health care utilization and infectious disease symptoms among infants over the first year of life. PLOS ONE 2019;14(12):e0226623 View
  4. Yates L, Thomas S. Prescribing medicines in pregnancy. Medicine 2016;44(7):438 View
  5. Koehn L, Huang Y, Habgood M, Kysenius K, Crouch P, Dziegielewska K, Saunders N. Effects of paracetamol (acetaminophen) on gene expression and permeability properties of the rat placenta and fetal brain. F1000Research 2020;9:573 View
  6. Kurz X. Advancing regulatory science, advancing regulatory practice. Pharmacoepidemiology and Drug Safety 2017;26(6):722 View
  7. Koehn L, Huang Y, Habgood M, Kysenius K, Crouch P, Dziegielewska K, Saunders N. Effects of paracetamol (acetaminophen) on gene expression and permeability properties of the rat placenta and fetal brain. F1000Research 2020;9:573 View
  8. Jongen P, Kremer I, Hristodorova E, Evers S, Kool A, van Noort E, Hiligsmann M. Adherence to Web-Based Self-Assessments in Long-Term Direct-to-Patient Research: Two-Year Study of Multiple Sclerosis Patients. Journal of Medical Internet Research 2017;19(7):e249 View
  9. Dreyer N, Rodriguez A. The fast route to evidence development for value in healthcare. Current Medical Research and Opinion 2016;32(10):1697 View
  10. Dreyer N, Hall M, Christian J. Modernizing Regulatory Evidence with Trials and Real-World Studies. Therapeutic Innovation & Regulatory Science 2020;54(5):1112 View
  11. Lupattelli A, Spigset O, Nordeng H. Learning the effects of psychotropic drugs during pregnancy using real-world safety data: a paradigm shift toward modern pharmacovigilance. International Journal of Clinical Pharmacy 2018;40(4):783 View
  12. Dreyer N, Reynolds M, DeFilippo Mack C, Brinkley E, Petruski-Ivleva N, Hawaldar K, Toovey S, Morris J. Self-reported symptoms from exposure to Covid-19 provide support to clinical diagnosis, triage and prognosis: An exploratory analysis. Travel Medicine and Infectious Disease 2020;38:101909 View
  13. Dreyer N, Petruski-Ivleva N, Albert L, Mohamed D, Brinkley E, Reynolds M, Toovey S. Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19. International Journal of General Medicine 2021;Volume 14:3941 View
  14. Dreyer N, Reynolds M, Albert L, Brinkley E, Kwon T, Mack C, Toovey S. How frequent are acute reactions to COVID-19 vaccination and who is at risk?. Vaccine 2022;40(12):1904 View
  15. Dolk H, Damase‐Michel C, Morris J, Loane M. COVID‐19 in pregnancy—what study designs can we use to assess the risk of congenital anomalies in relation to COVID‐19 disease, treatment and vaccination?. Paediatric and Perinatal Epidemiology 2022;36(4):493 View
  16. Reynolds M, Xie Y, Knuth K, Mack C, Brinkley E, Toovey S, Dreyer N. COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness. Infection and Drug Resistance 2022;Volume 15:5167 View
  17. Richardson J, Moore A, Bromley R, Stellfeld M, Geissbühler Y, Bluett-Duncan M, Winterfeld U, Favre G, Alexe A, Oliver A, van Rijt-Weetink Y, Hodson K, Rezaallah B, van Puijenbroek E, Lewis D, Yates L. Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project. Drug Safety 2023;46(5):479 View
  18. Largent J, Xie Y, Knuth K, Toovey S, Reynolds M, Brinkley E, Mack C, Dreyer N. Cognitive and other neuropsychiatric symptoms in COVID-19: analysis of person-generated longitudinal health data from a community-based registry. BMJ Open 2023;13(6):e069118 View
  19. Dreyer N, Knuth K, Xie Y, Reynolds M, Mack C. COVID-19 Vaccination Reactions and Risk of Breakthrough Infections Among People With Diabetes: Cohort Study Derived From Community Reporters. JMIR Diabetes 2024;9:e45536 View
  20. Dreyer N, Blackburn S. Power to the people: why person-generated health data are important for pharmacoepidemiology. American Journal of Epidemiology 2024;193(9):1215 View
  21. Pirmani A, Oldenhof M, Peeters L, De Brouwer E, Moreau Y. Accessible Ecosystem for Clinical Research (Federated Learning for Everyone): Development and Usability Study. JMIR Formative Research 2024;8:e55496 View

Books/Policy Documents

  1. Dreyer N, Macedo A, Velentgas P. Pharmacoepidemiology. View
  2. Velentgas P. Textbook of Pharmacoepidemiology. View